Search research articles
Contact Us
Filters
Showing results (111-120 of 136) with videos related to
Page
of 14
Sort By:
The Journal of Allergy and Clinical Immunology
|
December 26, 2025
Somatic STAT5B<sup>N642H</sup> mutations shape variable immune landscapes resulting in heterogenous immune diseases
Sarah Grün, Anne Rensing-Ehl, Tobias Suske, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 20, 2022
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
Mathew Vithayathil, Antonio D'Alessio, Claudia A M Fulgenzi, et al.
Journal of Hepatology
|
April 3, 2022
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma
Maryam Barsch, Henrike Salié, Alexandra Emilia Schlaak, et al.
Cancer Cell
|
June 14, 2022
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma
Vidhya M Ravi, Paulina Will, Jan Kueckelhaus, et al.
Nature Aging
|
November 13, 2023
Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology
Julio Aguado, Alberto A Amarilla, Atefeh Taherian Fard, et al.
Hepatology International
|
April 3, 2023
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Mathew Vithayathil, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, et al.
Cancer Research
|
October 3, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia
Melissa Zwick, Bastian Zinkel, Corinna Spohr, et al.
World Journal of Gastrointestinal Oncology
|
December 11, 2023
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma
Sirish Dharmapuri, Umut Özbek, Hiren Jethra, et al.
Hepatology Communications
|
October 27, 2023
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study
Vincent Joerg, Bernhard Scheiner, Antonio D Alessio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 28, 2022
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study
Thomas Talbot, Antonio D'Alessio, Matthias Pinter, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 136) with videos related to
Sort By:
Page
of 14
The Journal of Allergy and Clinical Immunology
|
December 26, 2025
Somatic STAT5B<sup>N642H</sup> mutations shape variable immune landscapes resulting in heterogenous immune diseases
Sarah Grün, Anne Rensing-Ehl, Tobias Suske, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 20, 2022
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
Mathew Vithayathil, Antonio D'Alessio, Claudia A M Fulgenzi, et al.
Journal of Hepatology
|
April 3, 2022
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma
Maryam Barsch, Henrike Salié, Alexandra Emilia Schlaak, et al.
Cancer Cell
|
June 14, 2022
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma
Vidhya M Ravi, Paulina Will, Jan Kueckelhaus, et al.
Nature Aging
|
November 13, 2023
Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology
Julio Aguado, Alberto A Amarilla, Atefeh Taherian Fard, et al.
Hepatology International
|
April 3, 2023
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Mathew Vithayathil, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, et al.
Cancer Research
|
October 3, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia
Melissa Zwick, Bastian Zinkel, Corinna Spohr, et al.
World Journal of Gastrointestinal Oncology
|
December 11, 2023
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma
Sirish Dharmapuri, Umut Özbek, Hiren Jethra, et al.
Hepatology Communications
|
October 27, 2023
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study
Vincent Joerg, Bernhard Scheiner, Antonio D Alessio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 28, 2022
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study
Thomas Talbot, Antonio D'Alessio, Matthias Pinter, et al.
Page
of 14